InvestorsHub Logo
Followers 47
Posts 2562
Boards Moderated 0
Alias Born 05/15/2013

Re: None

Thursday, 04/16/2015 6:39:11 PM

Thursday, April 16, 2015 6:39:11 PM

Post# of 84961


HERBORIUM is working on several additions to its Product Portfolio. The near term products under development and consideration include:
The Liver Activator Series® Complimentary Liver Support Products that target liver damage resulting from Hepatitis C, Hepatitis B, and Cirrhosis and focus on regaining liver wellness compromised by alcohol, drugs and environmental factors. The leading product that supports both liver wellness and treatment is Liver Rejuvenator®

ProstAid an all natural product focused on Benign Prostate Hyperplasia (BPH) and ProstCare a similar product that targets Prostatitis

CardioVitae® a proprietary, fermentation based product using a Lucidium derived cell line targeting cardio-pulmonary insufficiencies. An enriched extract derived from a Ganoderma lucidium cell line that helps improve and accelerate recovery from cerebrovascular strokes is also under consideration.
The Company focuses on health needs with large market potential as defined by the number of patients and the demonstrated need for more satisfactory medical solutions.

Additional priority products identified by Herborium include:
Men’s Health (Benign Prostate Hyperplasia)
Hepatic Disease including Hepatitis and Cirrhosis and Improve hepatic function in patients with chronic liver disease
Antibiotic resistant pulmonary infections
Rheumatoid Arthritis
Cancer
Diabetes
GO HBRM $$$$$$

Penny stocks have earned their bad reputation, so beware.